APA (7th ed.) Citation

P, R., H, G., N, U., M, A., L, I., V, E., . . . G, G. (2023). Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system. Journal of controlled release : official journal of the Controlled Release Society, 364, 654. https://doi.org/10.1016/j.jconrel.2023.10.050

Chicago Style (17th ed.) Citation

P, Reus, et al. "Drug Repurposing for the Treatment of COVID-19: Targeting Nafamostat to the Lungs by a Liposomal Delivery System." Journal of Controlled Release : Official Journal of the Controlled Release Society 364 (2023): 654. https://doi.org/10.1016/j.jconrel.2023.10.050.

MLA (9th ed.) Citation

P, Reus, et al. "Drug Repurposing for the Treatment of COVID-19: Targeting Nafamostat to the Lungs by a Liposomal Delivery System." Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 364, 2023, p. 654, https://doi.org/10.1016/j.jconrel.2023.10.050.